Skip to main content
Thomas Oxley
Brain-Computer: The Next Frontier in Neurotechnology
Main Stage
Tuesday, March 05, 2024 14:20 - 14:35
The Power of the Mind
Health Tech
Monday, March 04, 2024 12:10 - 12:30
Fireside Chat
Neurotechnology to Unlock the Brain
Tuesday, March 05, 2024 17:10 - 17:30
Big Talk
Vascular neurologist driving innovation in brain-computer interfaces. Professor Thomas Oxley MBBS BMedSc FRACP PhD is a vascular and interventional neurologist and world expert in brain computer interfaces. He is founding CEO of brain computer interface company Synchron, based in New York City. He is Professor of Medicine and Laboratory Head of the Vascular Bionics Laboratory, University of Melbourne, Australia, as well as Clinical Instructor, Attending in the Department of Neurosurgery, Mount Sinai Hospital. Dr Oxley has performed over 1600 endovascular neurosurgical procedures, including cerebral aneurysm coiling and clot retrievals in acute stroke. Dr Oxley has published over 100 internationally peer reviewed articles in journals including Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine and The Lancet. He has over 120 patents filed with about 50 granted. He has raised over $140M in private capital and grants. Synchron is developing implantable neurotechnology that utilizes the blood vessels as the natural highways into the brain. The first product is currently in human clinical trials: a brain computer interface to enable people with impaired upper limb function to control digital devices directly from the brain. Synchron represents the advent of implantable electronics into the field of neurointervention.